331-345 of 847
Advancements in Multiple Sclerosis: Insights from the 2024 ACTRIMS Forum
NeuroFrontiersAdvancements in Multiple Sclerosis: Insights from the 2024 ACTRIMS Forum
Exploring the Latest in MS Cognitive Rehabilitation Strategies
NeuroFrontiersExploring the Latest in MS Cognitive Rehabilitation Strategies
Nancy Chiaravalloti, PhD
Visionary Insights: Assessing MS-Related Retinal Changes with Adaptive Optics
NeuroFrontiersVisionary Insights: Assessing MS-Related Retinal Changes with Adaptive Optics
Daniel Harrison, MD
Family Planning Clinical Considerations for Patients with Multiple Sclerosis
NeuroFrontiersFamily Planning Clinical Considerations for Patients with Multiple Sclerosis
Ashley Baker, MSN, PMHNP
Anna A. Shah, MD
Unmet Needs in Rehabilitation Research for Multiple Sclerosis
NeuroFrontiersUnmet Needs in Rehabilitation Research for Multiple Sclerosis
Robert Motl, PhD
New Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
Heart MattersNew Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
- advertisement
MS Research: Using Epigenetic Clocks and Biomarkers to Assess Biological Aging
NeuroFrontiersMS Research: Using Epigenetic Clocks and Biomarkers to Assess Biological Aging
Yinan Zhang, MD
Telehealth in MS Care: Addressing the Potential for Improvement and Concerns
NeuroFrontiersTelehealth in MS Care: Addressing the Potential for Improvement and Concerns
Marisa McGinley, DO
Addressing Healthcare Barriers in Patients with Multiple Sclerosis
NeuroFrontiersAddressing Healthcare Barriers in Patients with Multiple Sclerosis
Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
NeuroFrontiersToxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
Andrew Wilner, MD, FACP, FAAN
Marcus E. Peter, PhD
Schizophrenia Diagnosis: The Importance of a Collaborative Approach
NeuroFrontiersSchizophrenia Diagnosis: The Importance of a Collaborative Approach
Ashley Baker, MSN, PMHNP
Morris Goldman, MD
Dara Sanandaji
Examining the Role of Toxic Tau Proteins in Alzheimer's Disease
NeuroFrontiersExamining the Role of Toxic Tau Proteins in Alzheimer's Disease
Andrew Wilner, MD, FACP, FAAN
George Bloom, PhD
- advertisement
New Study Shows EBV-Specific T-Cells Contribute to MS Development
NeuroFrontiersNew Study Shows EBV-Specific T-Cells Contribute to MS Development
J. William Lindsey
A Successful and Safe Stem Cell Therapy for Progressive MS
NeuroFrontiersA Successful and Safe Stem Cell Therapy for Progressive MS
Charles Turck, PharmD, BCPS, BCCCP
Stefano Pluchino, MD, PhD
PBA Treatment May Reverse Signs of Alzheimer’s Disease
NeuroFrontiersPBA Treatment May Reverse Signs of Alzheimer’s Disease
Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
Jini Naidoo, PhD
